Results for tag: "Nulojix"

Nulojix is a market within the context of Immunosuppressive Drugs, which are used to prevent the body from rejecting a transplanted organ. Nulojix is a drug that is used to reduce the risk of organ rejection in patients who have received a kidney transplant. It works by suppressing the immune system, which helps to prevent the body from attacking the transplanted organ. Nulojix is typically used in combination with other immunosuppressive drugs, such as cyclosporine and tacrolimus. Nulojix is a relatively new drug, having been approved by the US Food and Drug Administration in 2013. It is currently available in the United States, Canada, and Europe. The drug is manufactured by Bristol-Myers Squibb and marketed by Astellas Pharma. Some other companies in the Nulojix market include Novartis, Pfizer, and Merck. These companies are involved in the research, development, and marketing of immunosuppressive drugs. Additionally, there are a number of generic drug manufacturers that produce generic versions of Nulojix. Show Less Read more